Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 8, 2012, Pages

  Graffe, Carolina Cannillo ^a,b   Bech, Jesper Nørgaard ^a   Lauridsen, Thomas Guldager ^a   Pedersen, Erling Bjerregaard ^a,b  

^a HOLSTEBRO HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Aldosterone; cAMP; Salt; Vasopressin; Water

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; AQUAPORIN 2; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP; EPITHELIAL SODIUM CHANNEL; PROSTAGLANDIN E2; RENIN; SODIUM CHLORIDE; VASOPRESSIN;

ADULT; AGED; ARTICLE; BETA CHAIN; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET; FEMALE; FREE WATER CLEARANCE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SODIUM EXCRETION; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION; URINE OSMOLALITY; VASOPRESSIN BLOOD LEVEL; WATER ABSORPTION;

EID: 84859776125     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00616.2011     Document Type: Article

References (47)

1. Barash I, Ponda MP, Goldfarb DS, Skolnik EY. A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 5: 693-697, 2010.
2. Belibi FA, Edelstein CL. Unified ultrasonographic diagnostic criteria for polycystic kidney disease. J Am Soc Nephrol 20: 6-8, 2009.
3. Bia MJ, Dewitt S, Forrest JN Jr. Dissociation between plasma, urine, and renal papillary cyclic AMP content following vasopressin and DDAVP. Am J Physiol Renal Fluid Electrolyte Physiol 237: F218-F225. 1979.
4. _ channel. In: Chloride Movements Across Cellular Membranes, (Advances in Molecular and Cell Biology), edited by Pusch M. San Diego, CA: Elsevier, vol. 38, 2007.
5. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, Rossier BC. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367: 463-467, 1994.
6. Deen PM, Croes H, van Aubel RA, Ginsel LA, van Os CH. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 95: 2291-2296, 1995.
7. Fuller PJ, Young MJ. Mechanisms of mineralocorticoid action. Hypertension 46: 1227-1235, 2005.
8. Funder JW. Mineralocorticoid receptors: distribution and activation. Heart Fail Rev 10: 15-22, 2005.
9. Gattone VH, Maser RL, Tian C, Rosenberg JM, Branden MG. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet 24: 309-318, 1999.
10. Graffe CC, Bech JN, Pedersen EB. Effect ofhigh and low sodium intake on urinary aquaporin-2 excretion in healthy humans. Am J Physiol Renal Physiol 302: F264-F275, 2012.
11. Higashihara E, Torres VE, Chapman AB, Grantham JJ, Bae K, Watnick TJ, Horie S, Nutahara K, Ouyang J, Krasa HB, Czerwiec FS. Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience. Clin J Am Soc Nephrol 6: 2499-2507, 2011.
12. Jensen KT, Carstens J, Ivarsen P, Pedersen EB. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 57: 529-540, 1997.
13. Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, Bichet DG, Marumo F. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med 332: 1540-1545, 1995.
14. Kemendy AE, Kleyman TR, Eaton DC. Aldosterone alters the open probability of amiloride-blockable sodium channels in A6 epithelia. Am J Physiol Cell Physiol 263: C825-C837, 1992.
15. Lauridsen TG, Vase H, Starklint J, Bech JN, Pedersen EB. Protein- enriched diet increases water absorption via the aquaporin-2 water channels in healthy humans. Nephrol Dial Transplant 25: 2502-2510, 2010.
16. Lauridsen TG, Vase H, Starklint J, Graffe CC, Bech JN, Nielsen S, Pedersen EB. Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels. BMC Nephrol 11: 28, 2010.
17. Lee YJ, Song IK, Jang KJ, Nielsen J, Frokiaer J, Nielsen S, Kwon TH. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol 292: F340-F350, 2007.
18. Marples D, Knepper MA, Christensen EI, Nielsen S. Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol Cell Physiol 269: C655-C664, 1995.
19. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knep-Per MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 92: 1013-1017, 1995.
20. Pacha J, Frindt G, Antonian L, Silver RB, Palmer LG. Regulation of Na channels of the rat cortical collecting tubule by aldosterone. J Gen Physiol 102: 25-42, 1993.
21. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 26: 543-547, 1984.
22. Pedersen EB, Eiskjaer H, Madsen B, Danielsen H, Egeblad M, Nielsen CB. Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transplant 8: 1064-1070, 1993.
23. Pedersen EB, Eiskjaer H, Madsen B, Danielsen H, Egeblad M, Nielsen CB. Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transplant 8: 1064-1070, 1993.
24. Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol 280: F860-F867, 2001.
25. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20: 205-212, 2009.
26. Persu A, Devuyst O. Transepithelial chloride secretion and cystogenesis in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 15: 747-750, 2000.
27. Rai T, Sekine K, Kanno K, Hata K, Miura M, Mizushima A, Marumo Sasaki S. Urinary excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol 8: 1357-1362, 1997.
28. Raphael KL, Strait KA, Stricklett PK, Miller RL, Nelson RD, Piontek KB, Germino GG, Kohan DE. Inactivation of Pkd1 in principal cells causes a more severe cystic kidney disease than in intercalated cells. Kidney Int 75: 626-633, 2009.
29. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824-827, 1994.
30. + channel. J Biol Chem 269: 12981-12986, 1994.
31. Sabolic I, Katsura T, Verbavatz JM, Brown D. The AQP2 water channel: effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats. J Membr Biol 143: 165-175, 1995.
32. Saito T, Ishikawa SE, Ando F, Okada N, Nakamura T, Kusaka I, Higashiyama M, Nagasaka S, Saito T. Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin. J Clin Endocrinol Metab 83: 4034-4040, 1998.
33. Schmid M, Mann JF, Stein G, Herter M, Nussberger J, Klingbeil A, Ritz E. Natriuresis-pressure relationship in polycystic kidney disease. J Hypertens 8: 277-283, 1990.
34. Smith LA, Bukanov NO, Husson H, Russo RJ, Barry TC, Taylor AL, Beier DR, Ibraghimov-Beskrovnaya O. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease. J Am Soc Nephrol 17: 2821-2831, 2006.
35. Starremans PG, Li X, Finnerty PE, Guo L, Takakura A, Neilson EG, Zhou J. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5= end of Pkd1. Kidney Int 73: 1394-1405, 2008.
36. Torres VE, Wang X, Ward CJ, Grantham JJ, Chapman AB, Guay- Woodford L, Bae KT, Thompson PA, Miller JP, Consortium CRISP. Urine cyclic AMP and aquaporin 2 in early autosomal dominant polycystic kidney disease. J Am Soc Nephrol 15: 221A, 2004.
37. Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10: 363-364, 2004.
38. Torres VE, Wilson DM, Burnett JC Jr, Johnson CM, Offord KP. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc 66: 1010-1017, 1991.
39. Torres VE, Wilson DM, Offord KP, Burnett JC Jr, Romero JC. Natriuretic response to volume expansion in polycystic kidney disease. Mayo Clin Proc 64: 509-515, 1989.
40. Veizis EI, Carlin CR, Cotton CU. Decreased amiloride-sensitive Na+ absorption in collecting duct principal cells isolated from BPK ARPKD mice. Am J Physiol Renal Physiol 286: F244-F254, 2004.
41. Verani RR, Silva FG. Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study. Mod Pathol 1: 457-463, 1988.
42. Wang D, Strandgaard S. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease. J Hypertens 15: 925-933, 1997.
43. Wang X, Gattone VH, Somlo S, Harris PC, Torres VE. Effectiveness of 0PC-41061 on polycystic kidney disease development in Pkd2WS25/- mice (Abstract). J Am Soc Nephrol 16: 341A, 2005.
44. Wang X, Harris PC, Somlo S, Batlle D, Torres VE. Effect of calcium- sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrol Dial Transplant 24: 526-534, 2009.
45. Wen H, Frokiaer J, Kwon TH, Nielsen S. Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway. J Am Soc Nephrol 10: 1416-1429, 1999.
46. Yamaguchi T, Nagao S, Kasahara M, Takahashi H, Grantham JJ. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 30: 703-709, 1997.
47. Yamamoto T, Sasaki S, Fushimi K, Ishibashi K, Yaoita E, Kawasaki K, Marumo F, Kihara I. Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol Cell Physiol 268: C1546-C1551, 1995.